Advances in biomedical research have significantly expanded the role of molecular and physiological indicators in clinical decision-making. Among the most influential of these developments is the increasing use of biomarkers to guide diagnosis, risk assessment, treatment selection, and disease monitoring. Biomarker-guided medicine represents a core component of precision medicine, emphasizing the use of measurable biological signals to inform individualized clinical care.

A multidisciplinary community committed to advancing research, education, and clinical standards in precision medicine.
Copyright 2026. American Board of Precision Medicine. All Rights Reserved.